Previous 10 | Next 10 |
Inari Medical (NASDAQ: NARI) went public in what should have been one of the most difficult times for a non-COVID related healthcare company ever -- May 2020. Yet it has ridden the success of its clot-removing devices -- the FlowTriever and ClotTriever -- to 124% gains since. ...
IRVINE, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, announced today that its manage...
Stocks can make fools of even the smartest people. Many have been calling the current market a bubble for years. The price-to-sales (P/S) ratio of the Nasdaq Composite reached 2.6 in 2007 before crashing. It surpassed that by the end of 2015, leading many to point to another imminent collap...
IRVINE, Calif., July 27, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, announced today it will release...
IRVINE, Calif., June 22, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today announced the appointment of Ms. Rebecca Ch...
IRVINE, Calif., June 07, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today announced strongly positive interim results...
According to the CDC, up to 600,000 Americans are diagnosed with deep vein thrombosis (DVT) or pulmonary embolisms (PE) each year. These blood clots kill between 60,000 and 100,000 people annually, often within months of a diagnosis. Inari Medical (NASDAQ: NARI) , which came pub...
Market volatility has been called the price of admission for the higher returns that stocks offer relative to other assets. That doesn't make it easier to ride out a downturn. It's why many suggest keeping some cash available to take advantage when even the best companies are dropping sharp...
If you have some cash lying around, now is a great time to invest in high-growth companies. Upstart (NASDAQ: UPST) stock has had an amazing 2021, running up 185%. But the stock is down about 30% from its peak. Inari Medical (NASDAQ: NARI) has run up 95% since its IPO last ye...
Image source: The Motley Fool. Inari Medical, Inc. (NASDAQ: NARI) Q1 2021 Earnings Call May 11, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Inari Medical, Inc. (NARI) Q1 2021 Earnings Call Transcript
News, Short Squeeze, Breakout and More Instantly...
IRVINE, Calif., July 16, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced that it will release its second quarter 2024...
Hagens Berman Encourages NARI Investors with Substantial Losses to Contact Firm Before July 12, 2024 Deadline San Francisco, California--(Newsfile Corp. - June 26, 2024) - Hagens Berman urges Inari Medical, Inc. (NASDAQ: NARI) investors who suffered substantial losses to submit your losses no...
2024-06-01 18:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...